Search alternatives:
mean decrease » a decrease (Expand Search)
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
mg decrease » a decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
50 mg » 10 mg (Expand Search)
mean decrease » a decrease (Expand Search)
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
mg decrease » a decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
50 mg » 10 mg (Expand Search)
-
1
-
2
-
3
-
4
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
5
-
6
-
7
-
8
-
9
Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis).
Published 2024Subjects: -
10
-
11
Proportion of participants with sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment value and to < 8100 mf/ml.
Published 2016“…<p>Proportion of participants with sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment value and to < 8100 mf/ml.…”
-
12
-
13
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …”
-
14
-
15
-
16
-
17
-
18
GSK343 decreased tumor stemness.
Published 2021“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
-
19
-
20
Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1.
Published 2021“…(C) Decrease in ISC markers, OLFM4 and SOX9 in <i>Mll1</i><sup><i>FC/FC; Vil-Cre-ERT2/+</i></sup> intestinal sections. …”